Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G for Apogee Therapeutics, Inc. Common Stock, $0.00001 par value per share (APGE).
- Disclosed ownership: 6%.
- Date of event: 31 Dec 2024.
RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G Report for Apogee Therapeutics, Inc. Common Stock, $0.00001 par value per share (APGE)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- APGE
- Shares outstanding
- 45,201,617 shares
- Disclosed Ownership
- 2,712,097 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 09:00:03 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 6% ownership in Apogee Therapeutics, Inc. Common Stock, $0.00001 par value per share (APGE) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 09:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 6% | 2,712,097 | 0 | 2,712,097 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong, M.D. | 6% | 2,712,097 | 0 | 2,712,097 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D. |